Skip to main content
. 2024 Sep 11;10(18):e37843. doi: 10.1016/j.heliyon.2024.e37843

Table 1.

Characteristics of patients undergoing cardiac surgery.

Characteristic All patients (N = 8186) Preoperative anemiaa
No
Yes
ΔHbb < 50 % (n = 5447) ΔHb ≥50 % (n = 869) P ΔHb <30 % (n = 851) ΔHb ≥30 % (n = 1019) P
Preoperative factors
Age, year 52.0 (45.0–61.0) 51.0 (44.0–60.0) 56.0 (48.0–63.0) <0.001 49.0 (42.0–60.0) 57.0 (48.0–65.0) <0.001
Female 4720 (57.7) 3174 (58.3) 435 (50.1) <0.001 576 (67.7) 535 (52.5) <0.001
BMI, kg/m2 22.7 (20.8–24.7) 22.7 (21.1–25.0) 22.7 (21.0–24.5) 0.034 22.3 (20.2–23.7) 22.5 (20.3–24.0) 0.446
Current smoking 2291 (28.0) 1498 (27.5) 289 (33.3) <0.001 188 (22.1) 316 (31.0) <0.001
ASA classification 0.027 0.502
 II-III 7696 (94.0) 5165 (94.8) 808 (93.0) 788 (92.6) 935 (91.8)
 IV-V 490 (6.0) 282 (5.2) 61 (7.0) 63 (7.4) 84 (8.2)
NYHA classification 0.264 0.807
 I 144 (1.8) 91 (1.7) 17 (2.0) 18 (2.1) 18 (1.8)
 II 2006 (24.5) 1348 (24.7) 214 (24.6) 202 (23.7) 242 (23.7)
 III 5765 (70.4) 3879 (71.2) 608 (70.0) 576 (67.7) 702 (68.9)
 IV 271 (3.3) 129 (2.4) 30 (3.5) 55 (6.5) 57 (5.6)
Comorbidities
Chronic obstructive pulmonary disease 67 (0.8) 38 (0.7) 10 (1.2) 0.158 7 (0.8) 12 (1.2) 0.448
Hypertension 1341 (16.4) 788 (14.5) 179 (20.6) <0.001 148 (17.4) 226 (22.2) 0.010
Coronary heart disease 1060 (12.9) 567 (10.4) 151 (17.4) <0.001 117 (13.7) 225 (22.1) <0.001
One diseased vessel 231 (2.8) 138 (2.5) 30 (3.5) 31 (3.6) 32 (3.1)
 Two diseased vessels 193 (2.4) 99 (1.8) 29 (3.3) 19 (2.2) 46 (4.5)
 Three diseased vessels 519 (6.3) 273 (5.0) 82 (9.4) 56 (6.6) 108 (10.6)
 Not investigated 117 (1.4) 57 (1.0) 10 (1.2) 11 (1.3) 39 (3.8)
Previous myocardial infarction 229 (2.8) 119 (2.2) 30 (3.5) 0.023 27 (3.2) 53 (5.2) 0.033
Infective endocarditis 190 (2.3) 44 (0.8) 8 (0.9) 0.733 76 (8.9) 62 (6.1) 0.020
Atrial fibrillation 3723 (45.5) 2567 (47.1) 462 (53.2) 0.001 306 (36.0) 388 (38.1) 0.345
Previous congestive heart failure 1511 (18.5) 993 (18.2) 171 (19.7) 0.307 174 (20.4) 173 (17.0) 0.055
Peripheral arterial disease 112 (1.4) 62 (1.1) 12 (1.4) 0.538 13 (1.5) 25 (2.5) 0.162
Previous cardiovascular surgery 1825 (22.3) 1081 (19.8) 237 (27.3) <0.001 186 (21.9) 321 (31.5) <0.001
Previous transient ischemic attack 36 (0.4) 28 (0.5) 3 (0.3) 0.511 3 (0.4) 2 (0.2) 0.521
Previous stroke 336 (4.1) 203 (3.7) 36 (4.1) 0.551 50 (5.9) 47 (4.6) 0.221
Liver injury 412 (5.0) 263 (4.8) 53 (6.1) 0.111 46 (5.4) 50 (4.9) 0.627
Renal dysfunction 364 (4.4) 161 (3.0) 44 (5.1) 0.001 67 (7.9) 92 (9.0) 0.373
Diabetes mellitus 528 (6.5) 290 (5.3) 67 (7.7) 0.005 61 (7.2) 110 (10.8) 0.007
Echocardiography
Left ventricular functionc, % 0.514 0.091
 Good 7109 (86.8) 4704 (86.4) 755 (86.9) 766 (90.0) 884 (86.8)
 Moderate 1041 (12.7) 719 (13.2) 108 (12.4) 83 (9.8) 131 (12.9)
 Poor 36 (0.4) 24 (0.4) 6 (0.7) 2 (0.2) 4 (0.4)
Pulmonary hypertensiond, mmHg 0.288 0.010
Normal 6728 (82.2) 4526 (83.1) 725 (83.4) 646 (75.9) 831 (81.6)
 Mild 427 (5.2) 259 (4.8) 51 (5.9) 54 (6.3) 63 (6.2)
 Moderate 705 (8.6) 465 (8.5) 69 (7.9) 92 (10.8) 79 (7.8)
 Severe 326 (4.0) 197 (3.6) 24 (2.8) 59 (6.9) 46 (4.5)
Intraoperative factors
Type of surgery <0.001 <0.001
 Valve 7241 (88.5) 4692 (91.1) 721 (83.0) 750 (88.1) 808 (79.3)
 Coronary artery bypass grafting 794 (9.7) 401 (7.4) 116 (13.3) 91 (10.7) 186 (18.3)
 Both 151 (1.8) 84 (1.5) 32 (3.7) 10 (1.2) 25 (2.5)
Time on bypass, min 114.0 (89.0–142.0) 112.0 (88.0–138.0) 126.0 (100.0–158.0) <0.001 108.0 (85.0–137.0) 121.0 (94.0–149.0) <0.001
Cross-clamp time, min 75.0 (57.0–100.0) 73.0 (56.0–98.0) 82.0 (63.0–110.0) <0.001 71.0 (53.0–95.0) 81.0 (60.0–106.0) <0.001
Duration of surgery, h 4.8 (4.0–5.5) 4.7 (4.0–5.4) 5.3 (4.3–6.1) <0.001 4.6 (4.0–5.3) 5.0 (4.2–5.9) <0.001
Perioperative hemoglobin
Preoperative hemoglobine, g/dL 13.5 (12.3–14.6) 13.9 (13.1–14.8) 14.5 (13.7–15.4) <0.001 10.7 (9.6–11.5) 11.7 (11.1–12.1) <0.001
Postoperative nadir hemoglobinf g/dL 8.2 (7.3–9.0) 8.5 (7.8–9.4) 6.8 (6.1–7.1) <0.001 8.3 (7.7–8.8) 7.1 (6.6–7.7) <0.001
ΔHbb, % 38.5 (32.0–44.8) 38.7 (33.5–43.4) 53.5 (51.4–56.7) <0.001 22.4 (15.9–26.4) 37.4 (33.6–42.5) <0.001
Blood transfusion
Perioperative RBC transfusion 3915 (47.8) 1872 (34.4) 639 (73.5) <0.001 633 (74.4) 771 (75.7) 0.524
Total RBC, units 3.0 (2.0–5.0) 2.0 (2.0–4.0) 4.0 (2.0–7.5) <0.001 4.0 (2.0–5.0) 4.0 (2.0–6.0) 0.130
Intraoperative RBC transfusion 1957 (23.9) 891 (16.4) 196 (22.6) <0.001 427 (50.2) 443 (43.5) 0.004
Volume of intraoperative RBC transfusion, units 2.0 (2.0–4.0) 2.0 (2.0–3.0) 3.0 (2.0–6.0) <0.001 3.0 (2.0–4.0) 3.0 (2.0–4.0) 0.041
Postoperative RBC transfusion 2584 (31.6) 1222 (22.4) 501 (57.7) <0.001 384 (45.1) 477 (46.8) 0.466
Volume of postoperative RBC transfusion, units 3.0 (2.0–4.0) 2.0 (2.0–3.5) 4.0 (2.0–7.0) <0.001 3.0 (2.0–4.0) 3.5 (2.0–5.0) 0.047
Perioperative PLT transfusion 1078 (13.2) 601 (11.0) 156 (18.0) <0.001 130 (15.3) 191 (18.7) 0.048
Perioperative FFP transfusion 2462 (30.1) 1288 (23.6) 481 (55.4) <0.001 228 (26.8) 465 (45.6) <0.001

Values are presented as n (%) or median (interquartile range) unless otherwise noted. Continuous variables were compared using Student's t-test or Mann-Whitney U test, and categorical variables were compared using the chi-squared or Fisher's exact test.

a

Preoperative anemia was defined as preoperative hemoglobin <12 g/dL for women or <13 g/dL for men.

b

ΔHb (%) was defined as (Preoperative hemoglobin – Postoperative nadir hemoglobin)/Preoperative hemoglobin × 100.

c

Categorized as good when the left ventricular ejection fraction ≥51 %, as moderately reduced when the fraction was 31–50 %, or as poor when the fraction ≤30 %.

d

Classified as mild when pulmonary arterial pressure was 25–34 mmHg, as moderate when pressure was 35–44 mmHg, or as severe when ≥45 mmHg.

e

Preoperative hemoglobin was defined as the last available measurement before surgery.

f

Postoperative nadir hemoglobin was defined as the lowest level measured from ICU admission until day 3 after cardiac surgery.BMI, body mass index; ASA, American Society of Anesthesiologists; NYHA, New York Heart Association; RBC, red blood cell; PLT, platelet; FFP, fresh frozen plasma.